1. Home > Latest Topics >

Question 10: Major changes in empiric management of CAP

20 June, 2018

question_10_9


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Empiric Antibiotic Therapy for CAP in the Post-COVID-19 Era: Challenges and Insights
28 September, 2023
Community-acquired pneumonia: Insights into the current challenges and the role of levofloxacin
29 January, 2024
Management of community-acquired pneumonia in outpatient and inpatient settings: An overview
19 September, 2022
Optimising the management of patients with community-acquired pneumonia and comorbidities with levofloxacin
05 December, 2022
Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
20 April, 2023